News About: Pharm. Industry
LG/Novartis Korea on joint marketing of fluvastatin.
LG Life Science (President: Kim In-cheol) and Novartis Korea announced a joint marketing agreement on Feb. 6 for the distribution of fluvastatin, a cholesterol lowering drug under the trade names of Xylap XL by LG and...
Hyundai Pharm. to establish an independent software company.
Hyundai Pharmaceutical Co. announced that as of Feb. 1 the company established a separate and independent software companay called "Hyundai I&S" (president: Kim Yeon-kyu).
Hyundai I&S has operated an IT business s...
KFDA to settle down safety issue on Celebrex.
The KFDA decided to change labelling of all non-steroid anti-inflammatory drugs (NSAIDs) including celebrex, aceclofenac, meloxicam, ibuprofen and naproxen. Thus, the safety problem of Pfizer's Celebrex has been sorte...
Kwangdong seeking for overseas marketing of Vita500.
Based on the remarkable marketing success of Vita500 in Korea, Kwangdong is trying to extend to the overseas market in 2006 after having surveyed the markets in the North America, South America, China, Japan, South Ea...
NHI coverage extension for Zelmac in combined therapy.The NHI reimbursement seems to be extended to a combination therapy of Zelmac with other antispasmodics and GIT regulator drugs.
Novartis Korea said that Zelmac (tagaserod ...
|
SY Pharmtech to run technology transfer business.
While the government mulls a third party (toll) manufacturing permission for pharmaceutical products, SY pharmtech (president: Choi Soo-young) announced on Feb. 2 that the company is trying to run a technology transfe...
Sudo to appoint Park Sang-young as a strategic project director.
Sudo pharmaceutical company announced that Mr. Park Sang-young (45 years old), the former vice chairman of Korea Science Press Association was appointed as the standing director in charge of the strategic business pro...
Boryung reports slow sales and profit down in 2005.
Boryung pharmaceutical company announced the 2005 financial reports at 167,979 million won of sales, 5.9% down from the previous year, 6,839 million won of operating incomes and 5,938 million won of ordinary incomes, ...
Big public tenders to invite by Samsung and WAMC.
Samsung Medical Corporation and Workers Accident Medical Corporation announced to invite the public tenders for the purchase of drugs on Feb. 6, which showed a big business of keenly attracting wholesaler's interests....
CJ to declare a vision for top global pharmaceutical management.CJ Pharmaceutical Division took a declaration ceremony of "The Korea Top Global Pharmaceutical Company" to the Korea as well as the world at Daemyung Vivaldi park on Jan. 20 and...
|
